847 related articles for article (PubMed ID: 22682247)
1. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
[TBL] [Abstract][Full Text] [Related]
2. Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
Koyama-Nasu R; Hayashi T; Nasu-Nishimura Y; Akiyama T; Yamanaka R
Biochem Biophys Res Commun; 2015 Apr; 459(3):411-5. PubMed ID: 25735981
[TBL] [Abstract][Full Text] [Related]
3. Wnt signalling induces accumulation of phosphorylated β-catenin in two distinct cytosolic complexes.
Gerlach JP; Emmink BL; Nojima H; Kranenburg O; Maurice MM
Open Biol; 2014 Nov; 4(11):140120. PubMed ID: 25392450
[TBL] [Abstract][Full Text] [Related]
4. Molecular hydrogen suppresses activated Wnt/β-catenin signaling.
Lin Y; Ohkawara B; Ito M; Misawa N; Miyamoto K; Takegami Y; Masuda A; Toyokuni S; Ohno K
Sci Rep; 2016 Aug; 6():31986. PubMed ID: 27558955
[TBL] [Abstract][Full Text] [Related]
5. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
Tran H; Polakis P
J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
[TBL] [Abstract][Full Text] [Related]
6. Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity.
Pedersen NM; Thorvaldsen TE; Schultz SW; Wenzel EM; Stenmark H
PLoS One; 2016; 11(8):e0160507. PubMed ID: 27482906
[TBL] [Abstract][Full Text] [Related]
7. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
Schmitz Y; Rateitschak K; Wolkenhauer O
Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
[TBL] [Abstract][Full Text] [Related]
8. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
11. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
12. The roles of intrinsic disorder in orchestrating the Wnt-pathway.
Xue B; Dunker AK; Uversky VN
J Biomol Struct Dyn; 2012; 29(5):843-61. PubMed ID: 22292947
[TBL] [Abstract][Full Text] [Related]
13. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
14. WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway.
Goto T; Matsuzawa J; Iemura S; Natsume T; Shibuya H
FEBS Lett; 2016 May; 590(9):1291-303. PubMed ID: 27098453
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation.
Oh S; Gwak J; Park S; Yang CS
Biofactors; 2014; 40(6):586-95. PubMed ID: 25352148
[TBL] [Abstract][Full Text] [Related]
16. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation.
Gwak J; Oh J; Cho M; Bae SK; Song IS; Liu KH; Jeong Y; Kim DE; Chung YH; Oh S
Mol Pharmacol; 2011 Jun; 79(6):1014-22. PubMed ID: 21406604
[TBL] [Abstract][Full Text] [Related]
17. KCTD1 suppresses canonical Wnt signaling pathway by enhancing β-catenin degradation.
Li X; Chen C; Wang F; Huang W; Liang Z; Xiao Y; Wei K; Wan Z; Hu X; Xiang S; Ding X; Zhang J
PLoS One; 2014; 9(4):e94343. PubMed ID: 24736394
[TBL] [Abstract][Full Text] [Related]
18. AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.
Pećina-Šlaus N; Kafka A; Vladušić T; Pećina HI; Hrašćan R
Anticancer Res; 2016 Sep; 36(9):4583-94. PubMed ID: 27630299
[TBL] [Abstract][Full Text] [Related]
19. Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation.
Thorvaldsen TE; Pedersen NM; Wenzel EM; Stenmark H
PLoS One; 2017; 12(1):e0170508. PubMed ID: 28107521
[TBL] [Abstract][Full Text] [Related]
20. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]